skip to Main Content

About Us

The Intersection of Protein Engineering Experience, Expertise and Technology

adam-with-craft-beer-in-an-erlenmeyer-flask

Codexis, Inc. is a leading protein engineering company applying innovative technologies to unlock the power of proteins.

Since 2002, Codexis’ scientists and bioinformatics experts have worked collaboratively with our clients to advance protein optimization and production, enabling breakthrough developments in pharmaceuticals and fine chemicals, biotherapeutics, food & beverage, agriculture and a wide range of other industries.

code-evolver

Leveraged expertise

Guided by proprietary software and bioinformatic systems, Codexis leverages existing knowledge and expertise to improve protein stability, activity, specificity and other properties to enhance clinical function or process performance.

Our proprietary CodeEvolver® technology platform enables the rapid development and production of highly optimized proteins, custom-designed for your application. Codexis’ revolutionary approach to protein engineering starts with an understanding of the desired performance specifications and optimizes a protein specifically to fit these requirements. You get precisely the protein you need for the job you want it to do.

Selected milestones in our growth

  • Achieves defined endpoints in Phase 1a study of CDX-6114 — an engineered protein biotherapeutic for phenylketonuria (PKU)
    Press Release
  • Selected by National Association for Business Resources as one of the San Francisco Bay Area’s Best and Brightest Companies to Work For® second year in a row
    Press Release
  • Tate & Lyle commercializes TASTEVA® M Stevia Sweetener, thanks to novel bioconversion route enabled by Codexis-engineered enzymes
    Press Release
  • Launches global partnership with Porton Pharma Solutions to accelerate adoption of biocatalysis in small molecule pharmaceutical manufacture
    Press Release
  • Enters into health care-focused protein engineering platform partnership with Nestlé Health Science
    Press Release
  • Signs multi-year development agreement with Tate & Lyle to develop customized enzymes for food ingredients
    Press Release
  • Offers high-performance enzymes for diagnostic markets
    Press Release
  • Signs exclusive enzyme supply agreement with Tate & Lyle
    Press Release
  • Announces CodeEvolver® technology transfer and license agreement with Merck
    Press Release
  • Announces first biotherapeutic drug candidate for the treatment of PKU
    Press Release
  • Announces CodeEvolver® technology collaboration and license agreement with GSK
    Press Release
  • Introduces next-generation CodeXyme® cellulase enzymes
    Press Release
  • Wins third Presidential Green Chemistry Award in seven years
    Press Release
  • Granted patent for enzymes used in Hep-C therapeutics
    Press Release
  • Signs carbon capture agreement with Alcoa
    Press Release
  • Wins second Presidential Green Chemistry Challenge Award with Merck
    Press Release
  • Goes public with IPO
    Press Release
  • Signs first licensing agreement with Teva
    Press Release
  • Opens Singapore office
    Press Release
  • Acquires BioCatalytics, Pasadena, CA
    Press Release
  • Wins the first of three Presidential Green Chemistry Challenge Awards
    Press Release
  • Acquires Jülich Fine Chemicals, enabling expansion into Europe
    Press Release
  • Begins collaborations with Sandoz and Cargill, the first of many top-tier partnerships
  • Codexis is incorporated in California
    Press Release

Careers

The scientists, bioinformatics experts, and other professionals who make up the Codexis team share one goal: unlocking and advancing technologies for protein optimization and production to create better medicines, greener production processes and higher quality food ingredients. If that sounds like something you can get behind, consider a career at Codexis.

Current Opportunities
Back To Top
Close search
Search